NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Protinhi Therapeutics

Protinhi Therapeutics

Private
NijmegenHealthcare & Life Scienceshttps://www.protinhi.com/

Last Round

Grant

May 1, 2023

Total Funding Raised

$10.08M

Company Overview

Protinhi Therapeutics is a biotechnology company that develops a new class of drugs targeting proteases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

protease inhibitorsantiviral drugssmall molecule drugsdrug discoverybroad-spectrum antiviralsflavivirus treatmentdengue fever treatmentpandemic preparednessmedical countermeasuresbiotech licensingdrug discovery platformZika virus treatmentcoronavirus treatmentinfectious disease therapeuticspreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protinhi Therapeutics Comparables

Compare Protinhi Therapeutics with similar companies based on industry and business-model similarity.

Protinhi Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Island Pharmaceuticals Ltd
78%
Novartis
75%
Cocrystal Pharma Inc
73%

Protinhi Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2023
GrantMar 29, 2022
Series AFeb 13, 2019

Protinhi Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2023

    Received $8.2M from the European Innovation Council.

  • Mar 29, 2022

    Secured $1.88M from Eurostars SME programme.

Protinhi Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Protinhi Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Protinhi Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Year Founded2017
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.